Your browser version may not work well with NCBI's Web applications. More information here...
1: J Drugs Dermatol. 2003 Aug;2(4):404-8.Links

Vitiligo therapy: where are we now?

Arroyo MP, Tift L.

Ronald O Perelman Department of Dermatology, NYU School of Medicine, New York, New York, USA. mp.arroyo@stanfordalumni.org

Vitiligo is a disfiguring skin disease. Many insights into its pathogenesis have been identified in recent years; however, treatment remains a challenge. In this article, the various treatment options for the treatment of vitiligo are outlined and newer treatment options are discussed.

PMID: 12884463 [PubMed - indexed for MEDLINE]

Recent Activity